In a significant stride towards advancing pediatric cancer research, we are thrilled to announce that the state of Oregon has allocated a generous $1 million grant to the Children’s Cancer Therapy Development Institute (cc-TDI) during its 2023 legislative session. Designated specifically for the acquisition of state-of-the-art research equipment and technology, this investment further empowers researchers to conduct more precise and advanced studies, potentially leading to groundbreaking discoveries and reinforcing Oregon’s commitment to driving innovation in the fight against childhood cancer.
cc-TDI, known for its synergy with Oregon’s biotech and tech-bio industries, has been instrumental in incubating Silicon Forest area startups such as Veana Therapeutics and Datma. The $1 million investment represents a critical step in Oregon’s innovation and further strengthens cc-TDI’s position as a regional leader in pediatric cancer research.
“This generous grant from the state of Oregon empowers cc-TDI’s mission to bring effective, non-chemotherapy treatment options for childhood cancer to the children of Oregon and beyond,” explains cc-TDI’s Scientific Director, Dr. Charles Keller. “We are incredibly appreciative of the bipartisan support from Oregon lawmakers who believe so strongly in our mission and biotech in Oregon. This financial support will elevate our research efforts, accelerate the pace of discovery, and ultimately bring us closer to developing effective therapies for children and families.” Representative Nathan Sosa further expressed enthusiasm about the state’s investment in cc-TDI stating, “I am honored to have been able to advocate for the incredible work being done by the Children’s Cancer Therapy Development Institute. Their team of researchers are helping families as they work to save lives.”
Our heartfelt appreciation goes to Oregon legislators for their tireless advocacy on behalf of cc-TDI and their instrumental role in making this grant and future innovation possible. Specifically, Speaker Dan Rayfield, Senator Janeen Sollman, Senator Kate Lieber, Senator Elizabeth Steiner, Representative Rob Nosse, Representative Dr. Hai Pham, Representative Tawna Sanchez, Representative Ken Helm, and Representative Nathan Sosa.
This collaborative effort between cc-TDI and the state of Oregon underscores their shared commitment to advancing pediatric cancer research, giving hope to children and families affected by these devastating diseases.
